In vitro hepatic insulin resistance in chronic pancreatitis in the rat

Neal E. Seymour, Jon B. Turk, Morris K. Laster, Yasuhiro Tanaka, Howard E. Rosenberg, Edward A. Rademaker, Alberto Pochettino, Dana Andersen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

To investigate the effect of chronic pancreatitis (CP) on in vitro hepatic sensitivity to insulin, the suppression of glucagon-stimulated hepatic glucose production (HGP) by insulin was examined during isolated liver perfusion (ILP) in CP and sham-operated rats. CP was induced at laparotomy by infusion of 50 μl 99% oleic acid into the common bile duct during temporary occlusion of the proximal hepatic duct in 250- to 350-g Sprague-Dawley rats. Eight to sixteen weeks later, single-pass ILP was performed on fed animals. Glucagon (100 pg/ml) was infused for 30 min; the final 20 min of perfusion was performed with (a) no insulin, (b) 25 μ/ml insulin, or (c) 100 μU/ml insulin. CP and sham rats demonstrated comparable HGP responses to glucagon during the 0- to 10-min period (5.2 ± 0.5 vs 5.9 ± 0.5 mg/g/min, P = NS). CP rats demonstrated an HGP response to glucagon alone more evanescent than that in sham rats (20-30 min of HGP, 6.6 ± 0.6 vs 9.5 ± 0.4 mg/g/min, P <0.05). Sham rats showed a dose-dependent inhibition of HGP by insulin, however (percentage 20-30 min of HGP/0-10 min of HGP for 0, 25, and 100 μU/ml insulin: 166 ± 12, 125 ± 7, and 101 ± 5%, P <0.01), whereas CP rats showed no effect of insulin (130 ± 6, 123 ± 7, 134 ± 7%, P = NS). Pre- and postperfusion liver glycogen contents revealed comparable decreases in liver glycogen in both groups: insulin inhibition of HGP in sham rats was accompanied by higher postperfusion glycogen content. These data demonstrate a loss of insulin-mediated suppression of hepatic glucose production in livers obtained from pancreatitic rats. We conclude that CP is accompanied by a primary hepatic resistance to insulin; this defect may play a role in the etiology of pancreatogenic diabetes.

Original languageEnglish (US)
Pages (from-to)450-456
Number of pages7
JournalJournal of Surgical Research
Volume46
Issue number5
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Chronic Pancreatitis
Insulin Resistance
Liver
Insulin
Glucose
Glucagon
Liver Glycogen
Perfusion
In Vitro Techniques
Common Hepatic Duct
Common Bile Duct
Oleic Acid
Glycogen
Laparotomy
Sprague Dawley Rats

ASJC Scopus subject areas

  • Surgery

Cite this

Seymour, N. E., Turk, J. B., Laster, M. K., Tanaka, Y., Rosenberg, H. E., Rademaker, E. A., ... Andersen, D. (1989). In vitro hepatic insulin resistance in chronic pancreatitis in the rat. Journal of Surgical Research, 46(5), 450-456. https://doi.org/10.1016/0022-4804(89)90159-5

In vitro hepatic insulin resistance in chronic pancreatitis in the rat. / Seymour, Neal E.; Turk, Jon B.; Laster, Morris K.; Tanaka, Yasuhiro; Rosenberg, Howard E.; Rademaker, Edward A.; Pochettino, Alberto; Andersen, Dana.

In: Journal of Surgical Research, Vol. 46, No. 5, 1989, p. 450-456.

Research output: Contribution to journalArticle

Seymour, NE, Turk, JB, Laster, MK, Tanaka, Y, Rosenberg, HE, Rademaker, EA, Pochettino, A & Andersen, D 1989, 'In vitro hepatic insulin resistance in chronic pancreatitis in the rat', Journal of Surgical Research, vol. 46, no. 5, pp. 450-456. https://doi.org/10.1016/0022-4804(89)90159-5
Seymour NE, Turk JB, Laster MK, Tanaka Y, Rosenberg HE, Rademaker EA et al. In vitro hepatic insulin resistance in chronic pancreatitis in the rat. Journal of Surgical Research. 1989;46(5):450-456. https://doi.org/10.1016/0022-4804(89)90159-5
Seymour, Neal E. ; Turk, Jon B. ; Laster, Morris K. ; Tanaka, Yasuhiro ; Rosenberg, Howard E. ; Rademaker, Edward A. ; Pochettino, Alberto ; Andersen, Dana. / In vitro hepatic insulin resistance in chronic pancreatitis in the rat. In: Journal of Surgical Research. 1989 ; Vol. 46, No. 5. pp. 450-456.
@article{44fd411e86cd4c97a665e7415820cd5f,
title = "In vitro hepatic insulin resistance in chronic pancreatitis in the rat",
abstract = "To investigate the effect of chronic pancreatitis (CP) on in vitro hepatic sensitivity to insulin, the suppression of glucagon-stimulated hepatic glucose production (HGP) by insulin was examined during isolated liver perfusion (ILP) in CP and sham-operated rats. CP was induced at laparotomy by infusion of 50 μl 99{\%} oleic acid into the common bile duct during temporary occlusion of the proximal hepatic duct in 250- to 350-g Sprague-Dawley rats. Eight to sixteen weeks later, single-pass ILP was performed on fed animals. Glucagon (100 pg/ml) was infused for 30 min; the final 20 min of perfusion was performed with (a) no insulin, (b) 25 μ/ml insulin, or (c) 100 μU/ml insulin. CP and sham rats demonstrated comparable HGP responses to glucagon during the 0- to 10-min period (5.2 ± 0.5 vs 5.9 ± 0.5 mg/g/min, P = NS). CP rats demonstrated an HGP response to glucagon alone more evanescent than that in sham rats (20-30 min of HGP, 6.6 ± 0.6 vs 9.5 ± 0.4 mg/g/min, P <0.05). Sham rats showed a dose-dependent inhibition of HGP by insulin, however (percentage 20-30 min of HGP/0-10 min of HGP for 0, 25, and 100 μU/ml insulin: 166 ± 12, 125 ± 7, and 101 ± 5{\%}, P <0.01), whereas CP rats showed no effect of insulin (130 ± 6, 123 ± 7, 134 ± 7{\%}, P = NS). Pre- and postperfusion liver glycogen contents revealed comparable decreases in liver glycogen in both groups: insulin inhibition of HGP in sham rats was accompanied by higher postperfusion glycogen content. These data demonstrate a loss of insulin-mediated suppression of hepatic glucose production in livers obtained from pancreatitic rats. We conclude that CP is accompanied by a primary hepatic resistance to insulin; this defect may play a role in the etiology of pancreatogenic diabetes.",
author = "Seymour, {Neal E.} and Turk, {Jon B.} and Laster, {Morris K.} and Yasuhiro Tanaka and Rosenberg, {Howard E.} and Rademaker, {Edward A.} and Alberto Pochettino and Dana Andersen",
year = "1989",
doi = "10.1016/0022-4804(89)90159-5",
language = "English (US)",
volume = "46",
pages = "450--456",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - In vitro hepatic insulin resistance in chronic pancreatitis in the rat

AU - Seymour, Neal E.

AU - Turk, Jon B.

AU - Laster, Morris K.

AU - Tanaka, Yasuhiro

AU - Rosenberg, Howard E.

AU - Rademaker, Edward A.

AU - Pochettino, Alberto

AU - Andersen, Dana

PY - 1989

Y1 - 1989

N2 - To investigate the effect of chronic pancreatitis (CP) on in vitro hepatic sensitivity to insulin, the suppression of glucagon-stimulated hepatic glucose production (HGP) by insulin was examined during isolated liver perfusion (ILP) in CP and sham-operated rats. CP was induced at laparotomy by infusion of 50 μl 99% oleic acid into the common bile duct during temporary occlusion of the proximal hepatic duct in 250- to 350-g Sprague-Dawley rats. Eight to sixteen weeks later, single-pass ILP was performed on fed animals. Glucagon (100 pg/ml) was infused for 30 min; the final 20 min of perfusion was performed with (a) no insulin, (b) 25 μ/ml insulin, or (c) 100 μU/ml insulin. CP and sham rats demonstrated comparable HGP responses to glucagon during the 0- to 10-min period (5.2 ± 0.5 vs 5.9 ± 0.5 mg/g/min, P = NS). CP rats demonstrated an HGP response to glucagon alone more evanescent than that in sham rats (20-30 min of HGP, 6.6 ± 0.6 vs 9.5 ± 0.4 mg/g/min, P <0.05). Sham rats showed a dose-dependent inhibition of HGP by insulin, however (percentage 20-30 min of HGP/0-10 min of HGP for 0, 25, and 100 μU/ml insulin: 166 ± 12, 125 ± 7, and 101 ± 5%, P <0.01), whereas CP rats showed no effect of insulin (130 ± 6, 123 ± 7, 134 ± 7%, P = NS). Pre- and postperfusion liver glycogen contents revealed comparable decreases in liver glycogen in both groups: insulin inhibition of HGP in sham rats was accompanied by higher postperfusion glycogen content. These data demonstrate a loss of insulin-mediated suppression of hepatic glucose production in livers obtained from pancreatitic rats. We conclude that CP is accompanied by a primary hepatic resistance to insulin; this defect may play a role in the etiology of pancreatogenic diabetes.

AB - To investigate the effect of chronic pancreatitis (CP) on in vitro hepatic sensitivity to insulin, the suppression of glucagon-stimulated hepatic glucose production (HGP) by insulin was examined during isolated liver perfusion (ILP) in CP and sham-operated rats. CP was induced at laparotomy by infusion of 50 μl 99% oleic acid into the common bile duct during temporary occlusion of the proximal hepatic duct in 250- to 350-g Sprague-Dawley rats. Eight to sixteen weeks later, single-pass ILP was performed on fed animals. Glucagon (100 pg/ml) was infused for 30 min; the final 20 min of perfusion was performed with (a) no insulin, (b) 25 μ/ml insulin, or (c) 100 μU/ml insulin. CP and sham rats demonstrated comparable HGP responses to glucagon during the 0- to 10-min period (5.2 ± 0.5 vs 5.9 ± 0.5 mg/g/min, P = NS). CP rats demonstrated an HGP response to glucagon alone more evanescent than that in sham rats (20-30 min of HGP, 6.6 ± 0.6 vs 9.5 ± 0.4 mg/g/min, P <0.05). Sham rats showed a dose-dependent inhibition of HGP by insulin, however (percentage 20-30 min of HGP/0-10 min of HGP for 0, 25, and 100 μU/ml insulin: 166 ± 12, 125 ± 7, and 101 ± 5%, P <0.01), whereas CP rats showed no effect of insulin (130 ± 6, 123 ± 7, 134 ± 7%, P = NS). Pre- and postperfusion liver glycogen contents revealed comparable decreases in liver glycogen in both groups: insulin inhibition of HGP in sham rats was accompanied by higher postperfusion glycogen content. These data demonstrate a loss of insulin-mediated suppression of hepatic glucose production in livers obtained from pancreatitic rats. We conclude that CP is accompanied by a primary hepatic resistance to insulin; this defect may play a role in the etiology of pancreatogenic diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0024392171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024392171&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(89)90159-5

DO - 10.1016/0022-4804(89)90159-5

M3 - Article

C2 - 2654478

AN - SCOPUS:0024392171

VL - 46

SP - 450

EP - 456

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 5

ER -